We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
1526
BridgeBio Pharma
BBIO
$16.5B
$326K 0.01%
5,347
-2,232
-29% -$127K
CP icon
1527
Canadian Pacific Kansas City
CP
$80.5B
$326K 0.01%
4,244
-6,706
-61% -$520K
CSTL icon
1528
Castle Biosciences
CSTL
$979M
$326K 0.01%
4,448
+606
+16% +$40K
RWL icon
1529
Invesco S&P 500 Revenue ETF
RWL
$9.86B
$326K 0.01%
4,427
+2,226
+101% +$162K
SHLS icon
1530
Shoals Technologies Group
SHLS
$1.5B
$326K 0.01%
9,193
+6,949
+310% +$210K
SPTN
1531
DELISTED
SpartanNash
SPTN
$325K 0.01%
16,836
+15,249
+961% +$304K
MGC icon
1532
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
$324K 0.01%
+2,125
New +$314K
QYLD icon
1533
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.26B
$324K 0.01%
14,449
-52,579
-78% -$1.18M
KRTX
1534
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$324K 0.01%
2,842
+2,088
+277% +$244K
WPF
1535
DELISTED
Foley Trasimene Acquisition Corp.
WPF
$324K 0.01%
+33,109
New +$336K
APLS
1536
DELISTED
Apellis Pharmaceuticals
APLS
$323K 0.01%
5,111
+1,662
+48% +$85.8K
AXTA icon
1537
Axalta
AXTA
$8.17B
$323K 0.01%
10,591
+4,637
+78% +$147K
FNV icon
1538
Franco-Nevada
FNV
$46B
$323K 0.01%
+2,223
New +$322K
MSM icon
1539
MSC Industrial Direct
MSM
$6.86B
$323K 0.01%
3,595
-1,596
-31% -$146K
RAMP icon
1540
LiveRamp
RAMP
$2.3B
$323K 0.01%
6,887
-2,229
-24% -$107K
REGL icon
1541
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.82B
$323K 0.01%
4,533
+2,242
+98% +$163K
SKF icon
1542
ProShares UltraShort Financials
SKF
$10M
$322K 0.01%
3,968
+3,076
+345% +$258K
GBX icon
1543
The Greenbrier Companies
GBX
$1.46B
$321K 0.01%
7,355
+2,082
+39% +$96.2K
NAVI icon
1544
Navient
NAVI
$853M
$321K 0.01%
16,577
-3,986
-19% -$68.4K
SRG
1545
Seritage Growth Properties
SRG
$136M
$321K 0.01%
17,457
+14,843
+568% +$263K
VBK icon
1546
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$321K 0.01%
1,110
+1,081
+3,728% +$302K
FNDB icon
1547
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.45B
$320K 0.01%
+17,649
New +$317K
OFG icon
1548
OFG Bancorp
OFG
$2.21B
$320K 0.01%
14,454
-2,615
-15% -$62.1K
PTC icon
1549
PTC
PTC
$16B
$320K 0.01%
2,263
-9,739
-81% -$1.33M
BMRN icon
1550
BioMarin Pharmaceuticals
BMRN
$12.4B
$319K 0.01%
3,818
-19,047
-83% -$1.51M
60 61
62
63 64

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.